Breaking News

Possible factors in the DRC outbreak

December 9, 2024
When the Lockhard family was thrust into the bewildering world of ultra-rare disease, they found their way to someone they hoped could help, Terry Pirovolakis.
Rachel Woolf for STAT

STAT+ | This father built a gene therapy for his son. Now comes the harder part: saving others' children, too

Terry Pirovolakis built a gene therapy to save his son from a rare disease. He has become the first stop and last hope for other desperate parents.

By Jason Mast


STAT+ | Young biotech venture firm raises $500 million for its second fund

Dimension is capitalizing on the growing interest in AI startups in the biotech field.

By Allison DeAngelis


STAT+ | GSK myeloma medicine improves survival in trial, another step in the drug's revival

GSK reported at #ASH2024 that its drug Blenrep helped patients live longer in a pivotal trial.

By Andrew Joseph



Alex Kent/Getty Images

Police detain person of interest in UnitedHealthcare CEO killing

UnitedHealthcare CEO Brian Thompson was shot and killed as he walked to his company's investor meeting last week.

By Tara Bannow


STAT+ | Early treatment may delay or prevent multiple myeloma in high-risk patients, according to new study

Study finds benefit when Johnson & Johnson drug is given in the precancerous stage known as smoldering myeloma.

By Angus Chen


STAT+ | Pfizer's abrupt withdrawal of sickle cell drug Oxbryta called 'tone deaf' at ASH conference

Panelists at a STAT event said patients were despondent over how suddenly Oxbryta was pulled from the market and criticized the drug's rollout

By Meghana Keshavan


Alex Hogan/STAT, Google Earth

WHO sheds some light on factors possibly at play in DRC outbreak

In its statement, the WHO said there have been 406 recorded cases and 31 deaths — the latter number being at the low end of reports that have emerged.

By Helen Branswell


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments